Fundz

Omagh-based Sonas Pharma has secured pre-seed funding to advance research on obesity and epilepsy, led by SFC Capital. This investment will enhance its R&D capabilities and support the development of next-generation therapeutics.

PRIVATEMar 04, 2026

Round Type

Pre-Seed

Northern IrelandBiotechnologyHealth Care

Investors

SFC CapitalClarendon Fund Managers

Description

Sonas Pharma, a biotechnology company focusing on endocannabinoid system modulators, has completed a pre-seed funding round. The round was led by SFC Capital, with participation from Clarendon Fund Managers. The funds will be used for research into obesity and epilepsy, as well as expanding R&D capabilities. The company aims to address major unmet medical needs in these areas.

Quick answer

Sonas Pharma raised an undisclosed amount in a Pre-Seed round, dated March 4, 2026. Investors: SFC Capital and Clarendon Fund Managers. Sonas Pharma is based in Northern Ireland, United Kingdom.

How much did Sonas Pharma raise?
Sonas Pharma raised an undisclosed amount in a Pre-Seed round on March 4, 2026.
Who invested in Sonas Pharma?
SFC Capital and Clarendon Fund Managers are named as investors in this round.
What does Sonas Pharma do?
Sonas Pharma is a preclinical biotechnology company focused on developing best-in-class next-generation endocannabinoid system modulators for high-burden metabolic and neurological disorders.
Where is Sonas Pharma based and how big is it?
Sonas Pharma is based in Northern Ireland, United Kingdom.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Sonas Pharma that raised within 45 days of this round, from Fundz verified event records.

  • Athos Therapeutics, Inc. raised $10M on April 17, 2026.
  • Orthogon Therapeutics raised $11M (Funding Round) on April 17, 2026.
  • Enveric Biosciences raised $5M on April 17, 2026.
  • Ethermed raised $8.5M (Series A) on April 17, 2026.
  • Beeline Medicines raised $300M (Series A) on April 16, 2026.
  • STORM Therapeutics raised $56M (Series C) on April 16, 2026.

Who to call at Sonas Pharma, and when

A new round usually means Sonas Pharma is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Sonas Pharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Sonas Pharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Sonas Pharma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Sonas Pharma

Location

Northern Ireland, United Kingdom

About

Sonas Pharma is a preclinical biotechnology company focused on developing best-in-class next-generation endocannabinoid system modulators for high-burden metabolic and neurological disorders. Founded by Dr Chris Hayes and Dr Emma Cheetham, the company aims to address major unmet medical needs in epilepsy and obesity through innovative research. It operates as a privately held entity with a team dedicated to advancing life sciences and pharmaceutical innovation. The company seeks to build a high-value R&D base in Northern Ireland.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Sonas Pharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Sonas Pharma's next move

See what Strategic adds

Sonas Pharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.